SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹374 Cr | ₹265 Cr | ₹179 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹374 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹179 Cr |
How is Total Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹374 Cr | 41.19 | |
| Mar2024 | ₹265 Cr | 48.12 | |
| Mar2023 | ₹179 Cr | - | |
Compare Total Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,632.2 Cr | -1.8% | 12% | 48.9% | Stock Analytics | |
| SAGILITY | ₹18,734.7 Cr | 1.1% | -3% | -2.5% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,604.0 Cr | -2.8% | -5.6% | -31.7% | Stock Analytics | |
| PRIME FOCUS | ₹16,548.0 Cr | -13.4% | -11.9% | 88.9% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,335.2 Cr | -0.7% | -4.8% | -2.8% | Stock Analytics | |
| INDEGENE | ₹12,767.8 Cr | 2.7% | 4.3% | -6.9% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -1.8% |
12% |
48.9% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses